Pharmaceutical Formulation
Composition were developed which stabilize an active pharmaceutical ingredient in polymorph form susceptible to degradation or interconversion into other polymorph forms, where stabilizing substance is conveniently among silicon dioxide, silicified microcrystalline cellulose, magnesium oxide and pol...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | SVETE PETER GRAHEK ROK HUSU-KOVACEVIC BREDA HUMAR VLASTA JERALA-STRUKELJ ZDENKA |
| description | Composition were developed which stabilize an active pharmaceutical ingredient in polymorph form susceptible to degradation or interconversion into other polymorph forms, where stabilizing substance is conveniently among silicon dioxide, silicified microcrystalline cellulose, magnesium oxide and polyethylene glycol. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2007298108A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2007298108A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2007298108A13</originalsourceid><addsrcrecordid>eNrjZJAKyEgsyk1MTi0tyUxOzFFwyy_KLc1JLMnMz-NhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBUBNeakl8aHBRgYG5kaWFoYGFo6GxsSpAgD5VCRS</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Pharmaceutical Formulation</title><source>esp@cenet</source><creator>SVETE PETER ; GRAHEK ROK ; HUSU-KOVACEVIC BREDA ; HUMAR VLASTA ; JERALA-STRUKELJ ZDENKA</creator><creatorcontrib>SVETE PETER ; GRAHEK ROK ; HUSU-KOVACEVIC BREDA ; HUMAR VLASTA ; JERALA-STRUKELJ ZDENKA</creatorcontrib><description>Composition were developed which stabilize an active pharmaceutical ingredient in polymorph form susceptible to degradation or interconversion into other polymorph forms, where stabilizing substance is conveniently among silicon dioxide, silicified microcrystalline cellulose, magnesium oxide and polyethylene glycol.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2007</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20071227&DB=EPODOC&CC=US&NR=2007298108A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,778,883,25547,76298</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20071227&DB=EPODOC&CC=US&NR=2007298108A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SVETE PETER</creatorcontrib><creatorcontrib>GRAHEK ROK</creatorcontrib><creatorcontrib>HUSU-KOVACEVIC BREDA</creatorcontrib><creatorcontrib>HUMAR VLASTA</creatorcontrib><creatorcontrib>JERALA-STRUKELJ ZDENKA</creatorcontrib><title>Pharmaceutical Formulation</title><description>Composition were developed which stabilize an active pharmaceutical ingredient in polymorph form susceptible to degradation or interconversion into other polymorph forms, where stabilizing substance is conveniently among silicon dioxide, silicified microcrystalline cellulose, magnesium oxide and polyethylene glycol.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2007</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJAKyEgsyk1MTi0tyUxOzFFwyy_KLc1JLMnMz-NhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBUBNeakl8aHBRgYG5kaWFoYGFo6GxsSpAgD5VCRS</recordid><startdate>20071227</startdate><enddate>20071227</enddate><creator>SVETE PETER</creator><creator>GRAHEK ROK</creator><creator>HUSU-KOVACEVIC BREDA</creator><creator>HUMAR VLASTA</creator><creator>JERALA-STRUKELJ ZDENKA</creator><scope>EVB</scope></search><sort><creationdate>20071227</creationdate><title>Pharmaceutical Formulation</title><author>SVETE PETER ; GRAHEK ROK ; HUSU-KOVACEVIC BREDA ; HUMAR VLASTA ; JERALA-STRUKELJ ZDENKA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2007298108A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2007</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>SVETE PETER</creatorcontrib><creatorcontrib>GRAHEK ROK</creatorcontrib><creatorcontrib>HUSU-KOVACEVIC BREDA</creatorcontrib><creatorcontrib>HUMAR VLASTA</creatorcontrib><creatorcontrib>JERALA-STRUKELJ ZDENKA</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SVETE PETER</au><au>GRAHEK ROK</au><au>HUSU-KOVACEVIC BREDA</au><au>HUMAR VLASTA</au><au>JERALA-STRUKELJ ZDENKA</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Pharmaceutical Formulation</title><date>2007-12-27</date><risdate>2007</risdate><abstract>Composition were developed which stabilize an active pharmaceutical ingredient in polymorph form susceptible to degradation or interconversion into other polymorph forms, where stabilizing substance is conveniently among silicon dioxide, silicified microcrystalline cellulose, magnesium oxide and polyethylene glycol.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_US2007298108A1 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | Pharmaceutical Formulation |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T03%3A44%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SVETE%20PETER&rft.date=2007-12-27&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2007298108A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |